Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AMRX
AMRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AMRX News
Amneal and Zambon Receive Positive CHMP Opinion for Hopledo in Parkinson's Treatment
Jun 29 2026
NASDAQ.COM
EMA Recommends Approval of Hopledo for Parkinson's Disease
Jun 29 2026
NASDAQ.COM
Hopledo® Receives Positive CHMP Opinion for Parkinson's Treatment
Jun 29 2026
Newsfilter
Estrogen Patch Shortage Impacts Hormone Therapy
Jun 26 2026
CNBC
Amneal Pharmaceuticals Advances Drug Development with Positive ELEVATE-PD Results
Jun 13 2026
Yahoo Finance
Biotech Sector Sees Surge in FDA and Global Approvals
Jun 12 2026
NASDAQ.COM
Amneal's Commitment to Reliable Medicine Supply for Uninsured Patients
Jun 10 2026
PRnewswire
Amneal Supports Hope Alliance Campaign to Ensure Medicine Supply
Jun 10 2026
Newsfilter
CREXONT Phase 4 Study Shows Significant Clinical Benefits
Jun 05 2026
Newsfilter
Amneal Receives Approval for New Romidepsin Injection Solution
Jun 04 2026
Newsfilter
Amneal Pharmaceuticals Q1 2026 Earnings Exceed Expectations
May 08 2026
seekingalpha
Analysis of Risks and Opportunities in Value Stock Investment
May 04 2026
Yahoo Finance
Amneal Pharmaceuticals Q1 Earnings Preview
Apr 30 2026
seekingalpha
Amneal Pharmaceuticals Acquires Kashiv BioSciences, Paving the Way for Biosimilars Integration
Apr 22 2026
seekingalpha
U.S. Stocks Rise, Nasdaq Hits Record High
Apr 22 2026
NASDAQ.COM
U.S. Stocks Rise, Nasdaq Hits Record High
Apr 22 2026
NASDAQ.COM
Show More News
